Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_assertion type Assertion NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_head.
- NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_assertion description "[The estimated population-attributable risk of recurrence for FVL was 9.0% (95% CI, 4.5%-13.2%) and for prothrombin G20210A was 6.7% (95% CI, 3.4%-9.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_provenance.
- NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_assertion evidence source_evidence_literature NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_provenance.
- NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_assertion SIO_000772 16606808 NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_provenance.
- NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_assertion wasDerivedFrom befree-20140225 NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_provenance.
- NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_assertion wasGeneratedBy ECO_0000203 NP184895.RARNKOHrija5uAqkts11fdBMKYK4rkktjy-wMEJETsN3o130_provenance.